Patent details

EP2313422 Title: NUCLEOSIDE CYCLICPHOSPHATES

Basic Information

Publication number:
EP2313422
PCT Application Number:
PCT/US/2009/046619
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097633861
PCT Publication Number:
WO/2009/152095
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NUCLEOSIDE CYCLICPHOSPHATES
French Title of Invention:
NUCLÉOSIDE PHOSPHATES CYCLIQUES
German Title of Invention:
CYCLISCHE PHOSPHATE VON NUKLEOSIDEN
SPC Number:

Dates

Filing date:
08/06/2009
Grant date:
04/03/2015
EP Publication Date:
04/03/2015
PCT Publication Date:
17/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/04/2011
EP B1 Publication Date:
04/03/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/06/2015
Expiration date:
08/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/06/2009
 
 

Name:
Gilead Pharmasset LLC
Address:
c/o Gilead Sciences, Inc. 333 Lakeside Drive, Foster City, CA 94404, United States (US)

Inventor

1

Name:
ROSS Bruce, S.
Address:
United States (US)

2

Name:
NAGARATHNAM Dhanapalan
Address:
United States (US)

3

Name:
DU Jinfa
Address:
United States (US)

4

Name:
PAMULAPATI Ganapati, Reddy
Address:
United States (US)

5

Name:
SOFIA Michael, Joseph
Address:
United States (US)

Priority

1

Priority Number:
479075
Priority Date:
30/06/2006
Priority Country:
United States (US)

2

Priority Number:
60683 P
Priority Date:
11/06/2008
Priority Country:
United States (US)

3

Priority Number:
140369 P
Priority Date:
23/12/2008
Priority Country:
United States (US)

Classification

Main IPC Class:
C07H 19/10;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages